Immucell (ICCC) Intangibles (2016 - 2025)
Immucell's (ICCC) quarterly Intangibles came in at $4776.0 in Q3 2025, down 80.0% YoY from $23880.0 in Q3 2024, and down 50.0% on a QoQ basis from $9552.0 in Q2 2025.
Immucell (ICCC) Intangibles (2016 - 2025) Analysis & Trends
Immucell (ICCC) has 10 years of Intangibles data on file, last reported at $4776.0 in Q3 2025.
- Quarterly Intangibles fell 80.0% year-over-year to $4776.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $4776.0 (down 80.0% YoY) and the FY2024 annual result came in at $191040.0, up 400.0% from the prior year.
- Intangibles declined to $4776.0 in Q3 2025, from $9552.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $191040.0 in Q3 2021 to a low of $4776.0 in Q3 2025.
- A 5-year average of $129706.1 and a median of $191040.0 in 2021 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2024 — Intangibles soared 400.0% — and 2025, when it slumped 95.0%.
- Tracing ICCC's Intangibles over 5 years: stood at $191040.0 in 2021, then changed by 0.0% to $191040.0 in 2022, then tumbled by 80.0% to $38208.0 in 2023, then soared by 400.0% to $191040.0 in 2024, then tumbled by 97.5% to $4776.0 in 2025.
- The last three Intangibles figures came in at $4776.0 (Q3 2025), $9552.0 (Q2 2025), and $191040.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.99 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.92 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 55.73 Bn | 50.59 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.70 Bn | 9.31 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.32 Bn | 26.49 Bn | - | - |
| 10 | Immucell | 91.37 Mn | 82.51 Mn | 2.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 191,040.00 |
| Sep 30, 2025 | 4,776.00 |
| Jun 30, 2025 | 9,552.00 |
| Mar 31, 2025 | 191,040.00 |
| Dec 31, 2024 | 191,040.00 |
| Sep 30, 2024 | 23,880.00 |
| Jun 30, 2024 | 191,040.00 |
| Mar 31, 2024 | 191,040.00 |
| Dec 31, 2023 | 38,208.00 |
| Sep 30, 2023 | 42,984.00 |
| Jun 30, 2023 | 191,040.00 |
| Mar 31, 2023 | 191,040.00 |
| Dec 31, 2022 | 191,040.00 |
| Sep 30, 2022 | 191,040.00 |
| Jun 30, 2022 | 66,864.00 |
| Mar 31, 2022 | 191,040.00 |
| Dec 31, 2021 | 191,040.00 |
| Sep 30, 2021 | 191,040.00 |
| Jun 30, 2021 | 85,968.00 |
| Mar 31, 2021 | 90,744.00 |